Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
These Eli Lilly executives have been scooping up stock after its big drop
07:07pm, Tuesday, 12'th Aug 2025
After Eli Lilly & Co. shares fell sharply in the wake of disappointing trial data for its weight-loss pill, several of its executives and board members saw an opportunity to buy.
Final Trade: LLY, ULTA, AAPL, GDX
06:23pm, Tuesday, 12'th Aug 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
01:24pm, Tuesday, 12'th Aug 2025
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications.
Cramer Expects This FinTech To Reach $100, Upset With Eli Lilly: 'Come Back And Talk To Me'
08:20am, Tuesday, 12'th Aug 2025
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Affirm Holdings Inc AFRM is a buy. “It's at $72, it's going to $100,” he noted.
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Aug 2025)
08:00am, Tuesday, 12'th Aug 2025
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%.
2 All-American Dividend Gems To Buy Before The Market Wakes Up
07:30am, Tuesday, 12'th Aug 2025
I see Las Vegas' struggles as a mirror of broader economic woes of high prices, low consumer confidence, and trade uncertainty, pressuring markets and creating slim margins for error. I believe market
Why Eli Lilly Stock Popped Today
03:48pm, Monday, 11'th Aug 2025
Shares of Eli Lilly (LLY 1.49%), the pharmaceuticals giant and maker of the Mounjaro and Zepbound weight loss drugs, saw its stock bounce back a modest 2.5% through 1:55 p.m. ET Monday on some positiv
Can Eli Lilly Keep Up as NVO Eyes First Oral Obesity Pill Approval?
11:26am, Monday, 11'th Aug 2025
LLY's orforglipron study results disappoint, shifting investor focus to Novo Nordisk's bid for first FDA-approved oral obesity pill.
Lilly (LLY) Reliance on International Sales: What Investors Need to Know
10:15am, Monday, 11'th Aug 2025
Explore Lilly's (LLY) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 11'th Aug 2025
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Eli Lilly: Another Not-To-Miss Dip
11:08am, Saturday, 09'th Aug 2025
Eli Lilly's price fell with a thud yesterday following underwhelming drug trial results as the markets completely ignored strong Q2 2025 results. LLY's drop is immediately reminiscent of a similar plu
Why Eli Lilly Stock Sank 18% This Week
05:25pm, Friday, 08'th Aug 2025
Shares of Eli Lilly (LLY -2.37%) sank 18% this week, according to data from S&P Global Market Intelligence. The drugmaker with a market cap of over $500 billion is in a sharp drawdown due to previousl
Calls of the Day: Eli Lilly, E.L.F. Beauty and CRH PLC
01:49pm, Friday, 08'th Aug 2025
The Investment Committee debate the latest Calls of the Day and how to trade them.
Is Eli Lilly's 14% Post-Earnings Slide a Buy-the-Dip Opportunity?
12:00pm, Friday, 08'th Aug 2025
Industry pioneer Novo Nordisk A/S NYSE: NVO saw its stock drop nearly 22% on July 29 after lowering its full-year guidance. Then, on Aug. 7, Eli Lilly NYSE: LLY shares fell approximately 14%.
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data
12:00pm, Friday, 08'th Aug 2025
LLY tumbles despite solid Q2 results. ETFs like IHE, PPH, MEDX and MEDI with top exposure may offer buy-the-dip opportunities.
